Germany’s Colorectal Cancer market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around XX.X% during the forecast period.
Colorectal cancer is the most common cancer in Germany and the second most common cause of cancer-related deaths in both men and women. Germany is also the largest market shareholder for the colorectal Cancer market in Europe.
The rise in pipeline colorectal cancer screening tests is one of the major drivers for the colorectal cancer market. In Germany, screening colonoscopy with full insurance reimbursement is available for individuals aged 55 and above, and/or for persons with well-known risk factors for CRC.
Furthermore, the companies are focusing more on the development of new diagnostic tests that will help in the accurate detection of colorectal cancer which will further drive the market in future.